| Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis A Traboulsee, JH Simon, L Stone, E Fisher, DE Jones, A Malhotra, ... American Journal of Neuroradiology 37 (3), 394-401, 2016 | 390 | 2016 |
| Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions ME Smith, LA Stone, PS Albert, JA Frank, R Martin, M Armstrong, ... Annals of Neurology: Official Journal of the American Neurological …, 1993 | 334 | 1993 |
| The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosis LA Stone, JA Frank, PS Albert, C Bash, ME Smith, H Maloni, ... Annals of Neurology: Official Journal of the American Neurological …, 1995 | 330 | 1995 |
| Resting state sensorimotor functional connectivity in multiple sclerosis inversely correlates with transcallosal motor pathway transverse diffusivity MJ Lowe, EB Beall, KE Sakaie, KA Koenig, L Stone, RA Marrie, ... Human brain mapping 29 (7), 818-827, 2008 | 220 | 2008 |
| Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function D Michelson, L Stone, E Galliven, MA Magiakou, GP Chrousos, ... The Journal of Clinical Endocrinology & Metabolism 79 (3), 848-853, 1994 | 217 | 1994 |
| Increases in soluble VCAM‐1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β‐1b PA Calabresi, LR Tranquill, JM Dambrosia, LA Stone, H Maloni, CN Bash, ... Annals of Neurology: Official Journal of the American Neurological …, 1997 | 215 | 1997 |
| Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects PW O’connor, A Goodman, AJ Willmer-Hulme, MA Libonati, L Metz, ... Neurology 62 (11), 2038-2043, 2004 | 211 | 2004 |
| A safety and pharmacokinetic study of intravenous natalizumab in patients with MS WA Sheremata, TL Vollmer, LA Stone, AJ Willmer-Hulme, M Koller Neurology 52 (5), 1072-1072, 1999 | 172 | 1999 |
| Blood‐brain barrier disruption on contrast‐enhanced MRI in patients with mild relapsing‐remitting multiple sclerosis: relationship to course, gender, and age LA Stone, ME Smith, PS Albert, CN Bash, H Maloni, JA Frank, ... Neurology 45 (6), 1122-1126, 1995 | 161 | 1995 |
| Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure LA Stone, JA Frank, PS Albert, CN Bash, PA Calabresi, H Maloni, ... Neurology 49 (3), 862-869, 1997 | 146 | 1997 |
| Serial contrast‐enhanced magnetic resonance imaging in patients with early relapsing–remitting multiple sclerosis: Implications for treatment trials JA Frank, LA Stone, ME Smith, PS Albert, H Maloni, HF McFarland Annals of Neurology: Official Journal of the American Neurological …, 1994 | 117 | 1994 |
| Interferon-β-1b slows progression of atrophy in RRMS: three-year follow-up in NAb− and NAb+ patients JA Frank, N Richert, C Bash, L Stone, PA Calabresi, B Lewis, R Stone, ... Neurology 62 (5), 719-725, 2004 | 107 | 2004 |
| Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI PA Calabresi, LA Stone, CN Bash, JA Frank, HF McFarland Neurology 48 (5), 1446-1448, 1997 | 103 | 1997 |
| A randomized blinded trial of combination therapy with cyclophosphamide in patients with active multiple sclerosis on interferon beta DR Smith, B Weinstock-Guttman, JA Cohen, X Wei, C Gutmann, R Bakshi, ... Multiple Sclerosis Journal 11 (5), 573-582, 2005 | 101 | 2005 |
| Effects of meditation on pain and quality of life in multiple sclerosis and peripheral neuropathy: a pilot study J Tavee, M Rensel, SM Planchon, RS Butler, L Stone International journal of MS care 13 (4), 163-168, 2011 | 100 | 2011 |
| MRI as a marker for disease heterogeneity in multiple sclerosis B Bielekova, N Kadom, E Fisher, N Jeffries, J Ohayon, N Richert, ... Neurology 65 (7), 1071-1076, 2005 | 100 | 2005 |
| Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis LA Stone, PS Albert, ME Smith, C DeCarli, MR Armstrong, DE McFarlin, ... Neurology 45 (10), 1808-1814, 1995 | 86 | 1995 |
| Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis KA Koenig, KE Sakaie, MJ Lowe, J Lin, L Stone, RA Bermel, EB Beall, ... Magnetic resonance imaging 32 (4), 354-358, 2014 | 85 | 2014 |
| MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies HF McFarland, LA Stone, PA Calabresi, H Maloni, CN Bash, JA Frank Multiple Sclerosis Journal 2 (4), 198-205, 1996 | 85 | 1996 |
| An ImmunoChip study of multiple sclerosis risk in African Americans N Isobe, L Madireddy, P Khankhanian, T Matsushita, SJ Caillier, JM Moré, ... Brain 138 (6), 1518-1530, 2015 | 79 | 2015 |
